Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENONE vs CAPIVASERTIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANRENONE vs CAPIVASERTIB: Safety Overview

Metric CANRENONE CAPIVASERTIB
Total FAERS Reports 286 1,691
Deaths Reported 19 285
Death Rate 6.6% 16.9%
Hospitalizations 199 464
Average Patient Age 69.0 yrs 66.2 yrs
% Female Patients 51.8% 94.6%
FDA Approval Date N/A Nov 16, 2023
Manufacturer N/A AstraZeneca Pharmaceuticals LP
Route N/A ORAL
Marketing Status N/A Prescription